Vitrakvi (Larotrectinib) Dosage: A Comprehensive Guide for Indian Patients

Understanding Vitrakvi (Larotrectinib) Dosage for Cancer Treatment in India

Vitrakvi, known by its generic name larotrectinib, is a targeted therapy medication used to treat certain types of cancer. It is particularly effective for solid tumors that have a specific genetic mutation called a neurotrophin receptor tyrosine kinase (NTRK) gene fusion. This blog post aims to provide a clear and practical guide to Vitrakvi dosage for patients in India, covering its forms, strengths, recommended doses for adults and children, and what to do in case of an overdose. It is crucial to remember that this information is for educational purposes and should not replace the advice of your healthcare provider.

What is Vitrakvi and How Does it Work?

Vitrakvi belongs to a class of drugs called tyrosine kinase inhibitors. It works by targeting and blocking the activity of specific proteins that are produced by NTRK gene fusions. These fusions can lead to uncontrolled cell growth and the formation of tumors. By inhibiting these proteins, Vitrakvi helps to slow down or stop the growth of cancer cells.

Forms and Strengths of Vitrakvi

Vitrakvi is available in two main forms for oral administration:

• Oral Capsules: These are available in strengths of 25 milligrams (mg) and 100 mg. The capsules should be swallowed whole and not crushed or chewed.
• Oral Liquid Solution: This form is available as a solution containing 20 mg of Vitrakvi per milliliter (mg/mL). This can be a suitable option for individuals who have difficulty swallowing capsules.

Recommended Dosage for Adults

The standard recommended dosage of Vitrakvi for adults is 100 mg taken twice daily. It is important to adhere strictly to the dosage prescribed by your doctor. Your doctor will determine the most appropriate dose based on your individual condition, response to treatment, and any other health factors.

Dosage for Children

Vitrakvi is also prescribed for children aged 1 month and older who have tumors with NTRK gene fusions. The dosage for children is calculated based on their Body Surface Area (BSA), which is measured in square meters (sq m). The doctor will calculate the child's BSA before prescribing the medication.

For children with a BSA of 1 sq m or greater, the dosage is the same as for adults: 100 mg taken twice daily.

For children with a BSA of less than 1 sq m, the recommended dosage is 100 mg/sq m taken twice daily.

Important Administration Instructions

• Capsules: Always swallow Vitrakvi capsules whole. Do not crush, chew, or open them.
• Liquid Solution: If you are prescribed the liquid solution, use the measuring device provided by your doctor or pharmacist to ensure accurate dosing.
• Timing: Take Vitrakvi at approximately the same times each day, as prescribed by your doctor.
• With or Without Food: Vitrakvi can be taken with or without food.

Long-Term Treatment

Vitrakvi is often prescribed as a long-term treatment. If your doctor determines that the medication is safe and effective for your condition, you may continue taking it for an extended period. Regular monitoring by your healthcare team is essential during long-term therapy.

What to Do in Case of Overdose

Taking more Vitrakvi than prescribed can lead to harmful side effects. It is crucial to never exceed the dosage recommended by your doctor.

If you suspect you or someone else has taken too much Vitrakvi, take the following steps:

1. Contact your doctor immediately. They can provide specific guidance based on the amount taken and the symptoms observed.
2. Call emergency services: If you experience severe symptoms, call 112 (or your local emergency number in India) immediately or go to the nearest hospital emergency room.
3. Poison Control Centers: In India, you can also reach out to poison control centers for guidance. While the specific number may vary by region, your doctor or local hospital can provide the correct contact information.

Do not attempt to induce vomiting unless specifically instructed to do so by a medical professional.

When to Consult Your Doctor

It is essential to maintain open communication with your healthcare provider throughout your treatment with Vitrakvi. Consult your doctor if you experience any of the following:

• New or worsening symptoms.
• Side effects from the medication.
• Difficulty in taking the prescribed dose (e.g., swallowing capsules).
• Any concerns about your treatment plan.
• If you are pregnant, planning to become pregnant, or breastfeeding.

Conclusion

Vitrakvi is a vital medication for patients with specific types of solid tumors. Understanding the correct dosage, administration, and what to do in case of an overdose is crucial for effective and safe treatment. Always follow your doctor's instructions precisely and report any concerns promptly. This guide provides general information for Indian patients and should not substitute professional medical advice.